A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation

NO_LONGER_AVAILABLE

Conditions studied: Organ Transplantation

In brief

Facilitated access to everolimus until it is commercially available and reimbursable by appropriate parties

Key facts

Study ID

NCT00149981

Run by

Novartis Pharmaceuticals

Last updated by the study team

2019-09-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female recipients of solid organ transplants
• Subject is currently enrolled in an everolimus (RAD) trial sponsored by Novartis
• Currently on investigational drug everolimus (RAD) therapy

You may not qualify if…

• Inability or unwillingness to comply with immunosuppressive regimen.
• Pregnancy.
• History of acute organ rejection within the last 3 months.
• Other protocol-defined inclusion/exclusion criteria may apply.

Where it is running

• Novartis Investigative Site — Birmingham, Alabama, United States
• Novartis Investigative Site — Mobile, Alabama, United States
• Novartis Investigative Site — Los Angeles, California, United States
• Novartis Investigative Site — Los Angeles, California, United States
• Novartis Investigative Site — Los Angeles, California, United States
• Novartis Investigative Site — Los Angeles, California, United States
• Novartis Investigative Site — Los Angeles, California, United States
• Novartis Investigative Site — San Diego, California, United States
• Novartis Investigative Site — San Francisco, California, United States
• Novartis Investigative Site — Stanford, California, United States
• Novartis Investigative Site — Aurora, Colorado, United States
• Novartis Investigative Site — Denver, Colorado, United States
• Novartis Investigative Site — New Haven, Connecticut, United States
• Novartis Investigative Site — Gainesville, Florida, United States
• Novartis Investigative Site — Tampa, Florida, United States
• Novartis Investigative Site — Atlanta, Georgia, United States
• Novartis Investigative Site — Atlanta, Georgia, United States
• Novartis Investigative Site — Augusta, Georgia, United States
• Novartis Investigative Site — Chicago, Illinois, United States
• Novartis Investigative Site — Chicago, Illinois, United States
• Novartis Investigative Site — Maywood, Illinois, United States
• Novartis Investigative Site — Des Moines, Iowa, United States
• Novartis Investigative Site — Lexington, Kentucky, United States
• Novartis Investigative Site — New Orleans, Louisiana, United States
• Novartis Investigative Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.